Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rebecca J Gryka

Showing results (1-10 of 4) with videos related to

Pageof 1
Sort By:
Drugs in R&D|January 8, 2017
Vorapaxar: The Current Role and Future Directions of a Novel Protease-Activated Receptor Antagonist for Risk Reduction in Atherosclerotic DiseaseRebecca J Gryka, Leo F Buckley, Sarah M Anderson
American Journal of Pharmaceutical Education|June 20, 2015
Student Perceptions of Team-based Learning vs Traditional Lecture-based LearningTracy R Frame, Stephanie M Cailor, Rebecca J Gryka, et al.
The Journal of Pharmacy and Pharmacology|March 29, 2017
The antiproliferative and apoptotic effects of apigenin on glioblastoma cellsTrevor A Stump, Brittany N Santee, Lauren P Williams, et al.
Basic & Clinical Pharmacology & Toxicology|June 24, 2018
Luteolin Decreases Epidermal Growth Factor Receptor-Mediated Cell Proliferation and Induces Apoptosis in Glioblastoma Cell LinesDavid M Anson, Rachel M Wilcox, Eric D Huseman, et al.
Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:
Pageof 1
Drugs in R&D|January 8, 2017
Vorapaxar: The Current Role and Future Directions of a Novel Protease-Activated Receptor Antagonist for Risk Reduction in Atherosclerotic DiseaseRebecca J Gryka, Leo F Buckley, Sarah M Anderson
American Journal of Pharmaceutical Education|June 20, 2015
Student Perceptions of Team-based Learning vs Traditional Lecture-based LearningTracy R Frame, Stephanie M Cailor, Rebecca J Gryka, et al.
The Journal of Pharmacy and Pharmacology|March 29, 2017
The antiproliferative and apoptotic effects of apigenin on glioblastoma cellsTrevor A Stump, Brittany N Santee, Lauren P Williams, et al.
Basic & Clinical Pharmacology & Toxicology|June 24, 2018
Luteolin Decreases Epidermal Growth Factor Receptor-Mediated Cell Proliferation and Induces Apoptosis in Glioblastoma Cell LinesDavid M Anson, Rachel M Wilcox, Eric D Huseman, et al.
Pageof 1